NGF-ß, NE-Cells and Prostatic Cancer Cell Lines: A Study of Neuroendocrine Expression in the Human Prostatic Cancer Cell Lines DU-145, PC-3, LNCaP, and TSU-pr1 Following Stimulation of the Nerve Growth Factor-ß

References

• Abrahamsson PA, Wadstrom LB, Alumets J, Falkmer S. Grimelius L. Peptide-hormone and serotonin-immuno-reactive tumour cells in carcinoma of the prostate. Pathol Res Pract 1987; 182: 298–307.
   Google Scholar
• Abrahamsson PA, Falkmer S, Fält K, Grimelius L. The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker". Pathol Res Pract 1989; 185: 373–380.
   Google Scholar
• Allen F, VanVelden D, Heyns. Are neuroendocrine cells of practical value as an independent prognostic para-meter in prostate cancer? Br J Urol 1995; 75: 751–754.
   Google Scholar
• Angelsen A, Mecsei R, Sandvik AK, Waldum HL. Neuroendocrine cells in the prostate of the rat, guinea pig, cat and dog. Prostate: in press.
   Google Scholar
• Aprikian A, Cordon-Cardo C, Fan W, Reuter V. Charac-terization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 1993; 71: 3952–3965.
   PubMed Web of Science ®Google Scholar
• Berg MM, Steinberg DW, Hempstead BL, Chao MV. The low-affinity p75 nerve growth factor (NGF) re-ceptor mediates NGF-induced tyrosine phosphorylation. Proc Natl Acad Sci USA 1991; 88: 7106–7110.
   PubMed Web of Science ®Google Scholar
• Bonkhoff H, Stein U, Remberger K. Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic and neoplastic human prostate. Virch Arch A Pathol Anat 1993; 423: 291–294.
   Google Scholar
• Chung LW, Cunha GR. Stroma-epithelial interactions: II. Regulation of prostatic growth by embryonic sinus mesenchym. Prostate 1983; 4: 503–511.
   Google Scholar
• Cohen R, Glezerson 0, Haffejee Z. Neuro-endocrine cells: a new prognostic parameter in prostate cancer. Br J Urol 1991; 68: 258–262.
   Google Scholar
• Cunha GR. The role of androgens in epithelo-mesench-ymal interactions involved in prostatic morphogenesis in embryonic mice. Anat Rec 1973; 175: 87–96.
   PubMedGoogle Scholar
• Connoly JM, Rose DP. Secretion of epidermal growth factor and related polypeptides by the DU-145 human prostate cancer cell line. Prostate 1989; 15: 177–186.
   PubMed Web of Science ®Google Scholar
• Davies P, Eaton CL. Regulation of prostate growth. J Endocrinol 1991; 131: 5–17.
   PubMed Web of Science ®Google Scholar
• Dimaline R, Sandvik AK, Evans D, Forster ER, Dockray GJ. Food stimulation of histidine decarboxylase mes-senger RNA in rat gastric fundus. J Physiol 1993; 65: 449–458.
   Google Scholar
• Di Sant'Agnese PA, De Mesy-Jensen KL, Churucian CV, Agarwal MM. Human prostatic endo-paracrine (APUD) cells: distributional analysis with a comparison of serotonin and neuronspecific enolase immunoreactiv-ity and silver stains. Acta Pathol Lab Med 1985; 109: 607–612.
   PubMed Web of Science ®Google Scholar
• Di Sant'Agnese PA, Davis NS, Chen M, de Mesy Jensen KL. Age-related changes in the neuroendocrine (endo-crine-paracrine) cell population and the serotonin con-tent of the guinea pig prostate. Lab Invest 1987; 57: 729–36.
   PubMed Web of Science ®Google Scholar
• Djakiew D, Delsite R, Phlug B, Wrathall J, Lynch JH, Onoda M. Regulation of growth by a nerve growth factor-like protein which modulates paracrine interac-tions between a neoplastic epithelial cell line and stroma cells of the human prostate. Cancer Res 1991; 51: 3304–3310.
   PubMed Web of Science ®Google Scholar
• Djakiew D, Pflug BR, Delsite R, Onoda M, Lynch JH, Arand G, Thompson EW. Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal sectretory proteins containing a nerve growth factor-like protein. Cancer Res 1993; 53: 1416–1420.
   Google Scholar
• Epstein J, Partin A, Veltri R. Neuroendocrine differ-entiation (NE) in prostate cancer: enhanced prediction of progression following radical prostatectomy. Lab Invest 1995; 72: 75A.
   Google Scholar
• Graham CW, Lynch JH, Djakiew D. Distribution of nerve growth factor-like protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma. J Urol 1992; 147: 1444–1447.
   Google Scholar
• Greene LA, Tischler AS. Establishment of a noradre-nergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976; 73: 2424–2428.
   PubMed Web of Science ®Google Scholar
• Grube D. The endocrine cells of the digestive system: amines, peptides, and modes of action. Anat Embryol 1986; 175: 151–162.
   PubMedGoogle Scholar
• Hanyu S, Iwanaga T, Kano K, Fujita T. Distribution of serotonin-immunoreactive cells in the lower urinary tract of dogs. Am J Anat 1987; 180: 349–356.
   PubMedGoogle Scholar
• Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV. High-affinity NGF binding requires coexpression of the trk protooncogene and low-affinity NGF receptor. Nature 1991; 350: 678–683.
   PubMed Web of Science ®Google Scholar
• Hoosein NM, Logothetis CJ, Bandyk MG, Nicolson GL, Chung LWK. Expression of neuroendocrine factors and extracellular matrix degenerative enzymes in human prostate tumor cells. J Urol 1993; 149 (Suppl): 479.
   Google Scholar
• Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, et al. The LNCaP cell line-a new model for studies on human prostatic carcinomas. In: Murphy GP, ed. Models for prostate cancer. New York: Alan R Liss, Inc., 1980: 115–132.
   Google Scholar
• Hikanson R, Larsson L-I, Sjoberg N-0, Sundler F. Amine-producing endocrine-like cells in the epithelium of urethra and prostate of the guinea-pig. A chemical, fluorescence histochemical, and electron microscopic study. Histochemistry 1974; 38: 259–270.
   Google Scholar
• Iizumi T, Yazaki T, Kanoh S, Kondo I, Koiso K. Establishment of a new prostatic carcinoma cell line (TSU- prl). J Urol 1987; 137: 1304–1306.
   Google Scholar
• Janssen T, Darro F, Petein M, Raviv G, Pasteels J-L, Kiss R, Schulman CC. In vitro characterization of prolactin-induced effects on proliferation in the neo-plastic LNCaP, DU-145, and PC3 models of the human prostate. Cancer 1996; 77: 144–149.
   Google Scholar
• Kaighn ME, Shankar Narayan K, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979; 17: 16–23.
   PubMedGoogle Scholar
• Kirkland SC. Clonal origin of columnar, mucous and endocrine cell lineages in human colorectal epithelium. Cancer 1988; 61: 1359–1363.
   PubMed Web of Science ®Google Scholar
• Korsching S, Auburger G, Heumann R, Scott J, Thoenen H. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cho-linergic innervation. Eur Mol Biol Org 1985; 4: 1389–1393.
   Google Scholar
• Krijnen J, Janssen P. Ruizveld de Winter J, van Kimpen H, Schröder F, van der Kwast T. Do neuroendocrine cells in human prostate cancer express androgen receptor? Histochemistry 1993; 100: 393–398.
   Google Scholar
• Landis SC, Patterson PH. Neural crest cell lineages. Trends Neurosci 1981; 4: 172–174.
   Web of Science ®Google Scholar
• LeDouarin N, Teillet MA. The migration of neural crest cells to the wall of the digestive tract in avian embryos. J Embryol Exp Morphol 1972; 30: 31–38.
   Google Scholar
• MacDonald A, Habib FK. Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Int J Cancer 1992; 65: 177–182.
   Google Scholar
• McKeehan WL. Growth factor receptors and prostate cell growth. Cancer Surv 1991; 11: 165–175.
   PubMedGoogle Scholar
• Noordzij MA, van Weerden WM, de Ridder CMA, van der Kvast TH, Schröder FH, van Steenbrugge GJ. Neuroendocrine differentiation in human prostatic tumor models. Am J Pathol 1996; 149: 859–871.
   Google Scholar
• Pearse AGE, Polak JM. Cytochemical evidence for the neural crest origin of mammalian ultimobrachial C cells. Histochemie 1971; 27: 96–102.
   PubMedGoogle Scholar
• Pearse AGE, Takor T. Neuroendocrine embryology and the APUD cell concept. Clin Endocrinol Suppl 1976; 5: 299–344.
   Web of Science ®Google Scholar
• Pearse AGE. The APUD concept and hormone production. J Clin Endocrinol Metab 1980; 17: 211–222.
   Web of Science ®Google Scholar
• Peehl DM. Pro static growth factors, cancer, and steroid hormone activity. In: Vedeckis WV, ed. Hormones and cancer. Cambridge: Birkhäuser: in press.
   Google Scholar
• Plug BR, Onoda M, Lynch J, Djakiew D. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Res 1992; 52: 5403–5406.
   PubMed Web of Science ®Google Scholar
• Plug BR, Dione C, Kaplan DR, Lynch J, Djakiew D. Expression of a Trk high affinity nerve growth factor receptor in the human prostate. Endocrinology 1995; 136: 262–268.
   Google Scholar
• Ponder BAJ, Schmidt GH, Wilkinson MM, Wood M, Monk M, Reed A. Derivation of mouse intestinal crypts from single progenitor cells. Nature 1985; 313: 698–691.
   PubMed Web of Science ®Google Scholar
• Schuurmans ALG, Bolt J, Veldscholte J, Mulder E. Regulation of growth of LNCaP human prostate tumor cell cells by growth factors and steroid hormones. J Steroid Biochem Mol Biol 1991; 40: 193–197.
   PubMed Web of Science ®Google Scholar
• Serio M, Fiorelli G. Dual control by androgen and peptide growth factors of prostatic growth in human benign prostatic hyperplasia. Mol Cell Endocrinol 1991; 78: 77–81.
   Web of Science ®Google Scholar
• Steiner MS. Role of peptide growth factors in the prostate: a review. Urology 1993; 42: 99–110.
   PubMed Web of Science ®Google Scholar
• Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line. Int J Cancer 1978; 21: 274–281.
   Google Scholar
• Story MT. Polypeptide modulators of prostatic growth and development. Cancer Surv 1991; 11: 123–146.
   PubMedGoogle Scholar
• Stridsberg M, Oberg K, Qing L, Engstrom U, Lundquist G. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J Endocrinol 1995; 144: 49–59.
   Google Scholar
• Syversen U, Opsjon SL, Stridsberg M, Sandvik AK, Dimaline R, Tingulstad S, et al. Chromogranin A and pancreastin-like immunoreactivity in normal pregnan-cies. J Clin Endocrinol Metab 1996; 81: 4470–4475.
   PubMed Web of Science ®Google Scholar
• Van Haaften Day C, Raghavan D, Russell P, Wills EJ, Gregory P, Tilley W, et al. Xenografted small cell undifferentiated cancer of prostate: possible common origin with prostatic adenocarcinoma. Prostate 1987; 11: 271–279.
   PubMed Web of Science ®Google Scholar
• Vittoria A, La Mura E, Budetta G, Paino G, CostagliolaA, Cecio A. Immunocitochimica delle cellule a 5-HT nel complesso uretro-prostatico di Bubalus buffalus. Atti del 41° Convegno della Societa Italiana di Anatomia, Torino, 1986.
   Google Scholar
• Vittoria A, La Mura E, Cocca T, Cecio A. Serotonin-, somatostatin- and chromogranin A-containing cells of the urethro-prostatic complex in the sheep. An immuno-cytochemical and immunofluorescent study. J Anat 1990; 171: 169–178.
   Google Scholar
• Webber MM. Polypeptide hormones and the prostate. Murphy GP, Sandberg AA, Karr JP, eds. The prostate cell: structure, and function. Part B Prolactin, carcino-genesis and clinical aspects. New York: Alan R. Liss, 1981: 63–88.
   Google Scholar
• Weinstein MH, Partin AW, Veltri RW, Epstein J. Neuroendocrine differentiation in prostate cancer: en-hanced prediction of progression after radical prosta-tectomy. Hum Pathol 1996; 27: 683–687.
   PubMed Web of Science ®Google Scholar